Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sunil Patel currently holds 224,265 shares of OncoMed Pharmaceuticals Inc (OMED), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sunil Patel has been a net seller of OMED stock. They have purchased $488.4K and sold $11.1M worth of shares.
Sunil Patel's most recent insider trade was on Jan 30, 2023, when they sold 8,753 shares at $0.00 per share.
Sunil Patel serves as Executive at OncoMed Pharmaceuticals Inc (OMED). They have executed 61 insider transactions totaling $11.6M over their tenure at the company.
Sunil Patel holds the position of Executive at OncoMed Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Sunil Patel has shown a selling trading pattern, with $488.4K in total purchases and $11.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sunil Patel was on Aug 16, 2018, when they sold $10.2M worth of LGND shares. This transaction involved 42,287 shares at $240.05 per share.
Sunil Patel currently owns 224,265 shares of OncoMed Pharmaceuticals Inc (OMED), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sunil Patel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sunil Patel has 61 Form 4 filings on record as an insider at OncoMed Pharmaceuticals Inc.
Set alerts for Sunil Patel and 40,000+ other insiders.